September 2010

Monday, September 6, 2010 to Wednesday, September 8, 2010

The area of Biopatent Design is one that is rapidly involving, with new developments in refusing the Gene debate, developments in Biosimilars, protection issues with regards to DNA sequencing patents and new guidelines issued from the EPO. This is a very interesting time! Pharma IQ's BioPatent Design conference is your chance to address some of these issues, with internationally renowned representatives sharing their best practices and expertise, coupled with 10+ networking opportunities. Located in the heart of Munich, this is the perfect platform for you to: Implement best practices when designing bio patents, in order to gain first time approval, Analyze global patenting strategies to ensure that your patent is robust to withstand incoming attack, Incorporate efficient patent life-cycle management strategies maximize your patent revenue, Draw conclusions over patent type (gene patents, antibodies, DNA etc) to ensure first time approval of your patent.